Klinische Phase IIb: A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma

Minnich, B. (Consultant)

Activity: Consultancy and Expert OpinionExpert opinion

Description

Biometrisches Gutachten
Period22 May 2020
Work forEthikkommission des Landes Salzburg